Nizovtsev Alexander

Biography

2025: Appointment as CEO of Natsimbio

In July 2025, Alexander Nizovtsev was appointed CEO of Natsimbio Holding, the largest Russian manufacturer of vaccines and immunobiological drugs. The new manager has more than twenty years of management experience in the production of medicines and medical devices, including leadership positions in Pharmstandard.

It is noted that in his new position, Nizovtsev will strengthen the holding's market positions, taking into account the priority tasks of the corporation aimed at ensuring the country's sovereignty in the production and supply of immunobiological drugs.

𝓲

Фото: Rostec

Alexander Nizovtsev over the years worked in leadership positions in the pharmaceutical company Pharmstandard. He headed the plant TSMOI - one of the leading Russian manufacturers of medical equipment for infection control systems.

Nizovtsev led the I.I. Mechnikov vaccine and allergen production enterprise Biomed, where vaccines were traditionally produced for the National Vaccination Calendar. At this enterprise, technologies for the production of diagnostic and medical-diagnostic allergens have developed.

In his leadership position at Natsimbio, Alexander Nizovtsev replaced Andrei Zagorski, who headed the company since 2017. Zagorsky is moving to a new section of work within the framework of the Rostec corporation for the implementation of promising projects.

In his new position, Alexander Nizovtsev will focus on the further technological development of production in accordance with Eurasian and international GMP requirements. It is planned to attract additional investments in the development of the holding and the transfer of technologies.

The priority task of the new leader will be to bring to the market modern multivalent vaccines for the Russian health care system. This area of ​ ​ work is associated with the strengthening of the country's epidemiological security and ensuring technological sovereignty in the field of immunobiology.^[1]

Notes